Semin Thromb Hemost 1996; 22(4): 303-308
DOI: 10.1055/s-2007-999024
Copyright © 1996 by Thieme Medical Publishers, Inc.

Control Mechanisms in Thrombin Generation

Frederick A. Ofosu* , Longbin Liu* , John Freedman
  • *From the Canadian Red Cross Society, Blood Services, Hamilton, Ontario, Canada,
  • †Department of Pathology, McMaster University, Hamilton, and
  • ‡Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Further Information

Publication History

Publication Date:
06 February 2008 (online)

Abstract

Thrombin accelerates its own production by activating platelets (and perhaps other cells) to provide coagulant surfaces on which prothrombinase, the enzyme complex that activates prothrombin in plasma and consists of equimolar factor Xa (serine protease) and factor Va (cofactor), assembles in a Ca2+-dependent reaction. Thrombin also activates factor V to provide the cofactor for factor Xa in prothrombinase, and factor VIII to provide the cofactor for factor X activation by factor IXa. Even when factor X activation is initiated by tissue factor, efficient propagation of factor X activation is critically dependent on intrinsic tenase (the factor IXa and factor Villa enzyme complex). These procoagulant actions of thrombin explain why good antithrombins can inhibit both intrinsic and extrinsic prothrombin activation. Because of the low level of thrombin (1 nM) required to initiate platelet activation and the activation of platelet-bound factor V, only highly efficient antithrombins, such as hirudin, can abrogate plateletdependent prothrombinase assembly.